Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don’t understand how CV could affect reporting financials. Can’t the employee just email documents and participate in web meetings?
$HDII is one of a few green before circuit breakers kicked in! Big things coming! Come on Xu!!
That would be nice, there is no updates on this one. Nice to hear there hasn’t been any dilution.
Great timing for company to raise funds. We should bounce back soon $8+ once market stabilizes and we’ll blow past $10 on HE update expected soon. $BCLI
Best thing is great timing with manufacturing site coming online which means 40%+ margins coming for future production runs. $VRUS
Great news!! TJX excellent company to partner with and great to see green on a red day. Onward and upward with upcoming Fins. $VRUS
Some nice slapping going on. This kinda reminds me of last year where it took off after stop sign removed. We should see great fins released and future looks better with their own manufacturing site which will greatly improve margins. Sorry I didn’t sell some in Dec but still feel like we’ll see great growth in next ERs which should move us much higher. $VRUS
No uplisting should even be asked about until pps is 5x and volume is 10x current. You’ll end up with volume less than 2,000 per day like their other ticker.
After those mentioned catalysts we should see new indication announced which will give stock price additional boost.
Next catalysts should be ALS HE and interim MS phase 2 data, if strong enough will put pressure on FDA for conditional approval. JV similar to recent Biogen investment another, should see rise to teens in meantime or higher when they hit. $BCLI
Remember with the network marketing companies they are known to mark up services to pay commissions on it to up line distributors. Many times 100-400%, so with some of those mlm companies the end user might be paying $20 but its probably being marked up from $5-10 the mlm company is getting it from verb.
Correct, seems like pricing is all over the board. Some paying $5, some getting it for free trial and maybe some paying $10.
0, 15 or 20% capital gains tax on appreciation of shares sold for LT hold, 1+ years.
https://www.nerdwallet.com/blog/taxes/capital-gains-tax-rates/
a lot of catalyst coming up, in ALS Phase 3 and MS phase 2 trials with top line data due by end of year. HE (Hospital Exemption) results for 13 Israeli patients due in spring, interim results for ALS and Ms trials to come out before top line results in a month or so; and new indication to be announce, rumored to be Parkinsons. people might be thinking they have good chance for approval; they just met and got agreement from FDA to help them expedite when they are ready to submit data. $BCLI
Always good to take advantage of panic selling. Fundamentals are as strong as ever, short term speed bump is all. $VRUS
I believe we recover before end of day when smoke clears, maybe down but not where we are now, buying opportunity. Buy when people panic, we know fundamentals are great.
Good news is the irregularities don’t appear to impact anything substantial on financials. More of procedural error that needs to be addressed. Glad company issued PR to address it. You know company has huge numbers to report, feels like same spot we were in a year ago with stop sign issue when resolved we saw huge increase in pps. $VRUS
Dr Kern gave 25 minute presentation that summarized upcoming catalyst including
- top line results in Q4 for both ALS phase 3 and MS phase 2 trials
- new indication announced soon speculation it will be a Parkinsons
- Israeli HE results for the 11-13 ALS patients sometime March-April
- Interim results for both ALS and MS trials (not sure of timeframe but believe by June)
Here is link to his briefing:
https://www.globenewswire.com/Tracker?data=tVkHVI3v1mxmJRfCvNbYT24Ro0a-leXKpUbZF83u1DXivIsg6749l_w1w4wXvxUC6a-toMgrN6Duwm530CrfPOtxsX3p6XAv8SLZMcv0w0LkE0SdVdj5rTz9DxBNPwPvLTzFZ6uEkEhdg7HyZ6BIRDQ_qOjLWJR7LksmEmR12eIxZq4dRwIEtWaOjieKfzjjO8t0iHJkCBADXbZwD9qNDw==
Company on vacation today? No trades. That’s what makes RS very unlikely until price and volume greatly increase.
Yes and Dr Kern confirmed FDA will be considering data from all sources in its review.
They will need to get pps and volume way up before any RS, if not will barely get 1000 shares traded per day.
CMO Ralph Kern to present at investor conference today, this will be worth watching. Eventual buyout could be $3-$5B, thats $120-$200 pps. Kern came from Biogen, a potential suitor. http://ir.brainstorm-cell.com/news-releases/news-release-details/brainstorms-chief-operating-officer-present-noble-capital
Did we just turn green? Happy Friday! $VRUS
News!!! FDA must see this as potential approval to put in effort to work this out during trial. $BCLI
http://ir.brainstorm-cell.com/news-releases/news-release-details/brainstorm-cell-therapeutics-and-fda-agree-potential-nurownr?fbclid=IwAR159M3IO9Vd-c0YvQwALcXUGCfKX2diwZQ9JP9vdIW0gCvNL-ppd9lbOWg
Not sure if this new company / owners are legit but pps will skyrocket if they are. Pps reflects legacy company’s past history.
Seems strange price is going down right before company launch, website still reflects pre-launch state.
https://vitanax.com/
Wake me up when we get to $.05 $VRUS
You can get your questions answered on company’s website, here is investors letter ceo sent out that has links at bottom with lots of info on phase 3 als trial along with phase 2 MS. No info out there though on cost which will most likely be very high initially and then be reduced as they scale operations.
http://www.globenewswire.com/news-release/2019/12/18/1962038/0/en/BrainStorm-Issues-2019-Letter-to-Shareholders.html
Seems like wide spread bid/ask and level 2 thin to $.0175 $VRUS
That would be great, you going to trim some at that point or let it all ride to higher amount?
You’re right and so appropriate it’s $TSLA $ENRT #1 and 2
Now #3
A couple weeks ago, here is link to his blog:
https://tweedthoughts.com/2020/01/13/a-little-background/
From Matt Bellina’s blog on NurOwn: “I have had six injections and I have regained the ability to stand on my own without assistance. My lung capacity is 37% higher than it was before my first injection, so I no longer need the assistance of a breathing machine. I have gained enough mobility in my arms to scratch my face and even take my glasses off. All of these are improvements from where I was before the treatment.” $BCLI
Is this 2 green days in a row? Maybe we are on way back up and id like to think never coming back to these levels. $VRUS
When do we expect latest FIns? Usually we get a run up beforehand. Maybe this time we drift lower and then pop after release? Q4 should be great #s. Q2-2020 should show better margins as internally produced goods will be selling. Hanging tough. $VRUS
Even a small buyback will have tremendous affect on stock. Company should wait until they are at strength generating cash for regular buybacks before any uplist. IMO. $VRUS
It’s my view pps needs to be higher and more important volume needs to be at least 3-4x what it is now, too many times I see companies think uplist is cure all for anemic volume and pps and it turns out it isn’t.
There has to be much more volume and need higher pps before any uplist considered. $VRUS
Maybe I’ll get some more now.